A Phase 1B Study of AMG-232 in Combination With Decitabine in Acute Myeloid Leukemia
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2017
At a glance
- Drugs AMG 232 (Primary) ; Decitabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 20 Oct 2017 Planned End Date changed from 31 Mar 2019 to 31 Oct 2019.
- 20 Oct 2017 Planned primary completion date changed from 13 Mar 2019 to 31 Oct 2019.
- 20 Oct 2017 Status changed from not yet recruiting to recruiting.